Acorn Biolabs
Preparing your own best cells for personalized regenerative medicine.
Preparing your own best cells for personalized regenerative medicine.
Acorn Biolabs is a healthcare startup that was founded in 2017. The company recently received a significant $11.00M Series A investment on 03 June 2024, demonstrating strong investor confidence in its potential. The funding round was led by Telus Ventures and backed by notable investors such as Merz Aesthetics, Lee Li Holdings, MDE Investments, and The Leslie Group. This injection of capital is expected to fuel Acorn Biolabs' growth and further its efforts in the healthcare industry, positioning it for success in the market.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $11.00M | 5 |
|
03 Jun 2024 |
| Seed Round | $3.36M | 4 |
|
11 Jan 2019 |
| Grant | $25.00K | 1 |
|
21 Mar 2016 |
| Grant | $40.00K | - | 01 Jan 2016 |
No recent news or press coverage available for Acorn Biolabs.
We care about your data, and we'd love to use cookies make your experience better.
